Equillium Free Cash Flow Yield vs Price To Sales Ratio Analysis

EQ Stock

USD 0.71 0.01 1.39%

Equillium financial indicator trend analysis is much more than just examining Equillium latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Equillium is a good investment. Please check the relationship between Equillium Free Cash Flow Yield and its Price To Sales Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

Free Cash Flow Yield vs Price To Sales Ratio

Free Cash Flow Yield vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Equillium Free Cash Flow Yield account and Price To Sales Ratio. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Equillium's Free Cash Flow Yield and Price To Sales Ratio is 0.9. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Equillium, assuming nothing else is changed. The correlation between historical values of Equillium's Free Cash Flow Yield and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Equillium are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Free Cash Flow Yield i.e., Equillium's Free Cash Flow Yield and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Equillium stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Equillium sales, a figure that is much harder to manipulate than other Equillium multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Equillium's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Equillium current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.As of 11/25/2024, Selling General Administrative is likely to drop to about 10.3 M. In addition to that, Tax Provision is likely to drop to about 319 K

	2021	2022	2023	2024 (projected)
Other Operating Expenses	37.8M	54.8M	50.6M	38.1M
Depreciation And Amortization	72K	118K	126K	71.5K

Other Operating Expenses Depreciation And Amortization

Equillium fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.73	0.74	0.62	0.92	0.57	0.96	0.71	-0.87	-0.73	0.73	0.86	0.71	0.07	-0.38	1.0	0.9	0.58	0.65	-0.19	0.9	0.94	0.9	0.55	0.76	0.68
Short Long Term Debt Total	-0.73		-0.51	-0.66	-0.63	-0.6	-0.78	-0.49	0.65	0.71	-0.71	-0.55	-0.5	-0.24	0.66	-0.71	-0.68	-0.46	-0.92	0.76	-0.72	-0.6	-0.74	-0.33	-0.62	-0.53
Other Current Liab	0.74	-0.51		0.89	0.47	0.85	0.54	0.89	-0.89	-0.91	0.85	0.9	0.89	0.42	-0.41	0.7	0.86	0.93	0.49	0.07	0.88	0.89	0.91	0.95	0.32	0.88
Total Current Liabilities	0.62	-0.66	0.89		0.29	0.9	0.46	0.75	-0.74	-0.97	0.89	0.73	0.76	0.39	-0.45	0.58	0.77	0.89	0.61	-0.25	0.78	0.76	0.84	0.89	0.29	0.78
Total Stockholder Equity	0.92	-0.63	0.47	0.29		0.27	0.96	0.51	-0.71	-0.44	0.51	0.68	0.51	-0.08	-0.34	0.94	0.75	0.3	0.56	-0.19	0.75	0.76	0.72	0.24	0.8	0.47
Other Liab	0.57	-0.6	0.85	0.9	0.27		0.44	0.9	-0.75	-0.93	0.71	0.75	0.9	0.63	-0.31	0.53	0.73	0.92	0.56	-0.27	0.76	0.66	0.81	0.77	0.02	0.91
Net Tangible Assets	0.96	-0.78	0.54	0.46	0.96	0.44		0.58	-0.75	-0.6	0.62	0.72	0.58	0.0	-0.37	0.96	0.82	0.41	0.69	-0.37	0.82	0.81	0.8	0.31	0.79	0.56
Property Plant And Equipment Net	0.71	-0.49	0.89	0.75	0.51	0.9	0.58		-0.86	-0.85	0.68	0.87	1.0	0.57	-0.27	0.67	0.84	0.91	0.47	-0.03	0.87	0.77	0.87	0.76	0.11	0.99
Net Debt	-0.87	0.65	-0.89	-0.74	-0.71	-0.75	-0.75	-0.86		0.79	-0.7	-0.99	-0.85	-0.49	0.59	-0.85	-0.83	-0.73	-0.55	0.11	-0.87	-0.86	-0.89	-0.72	-0.46	-0.82
Retained Earnings	-0.73	0.71	-0.91	-0.97	-0.44	-0.93	-0.6	-0.85	0.79		-0.9	-0.78	-0.86	-0.37	0.37	-0.69	-0.88	-0.93	-0.66	0.28	-0.89	-0.83	-0.93	-0.85	-0.33	-0.88
Accounts Payable	0.73	-0.71	0.85	0.89	0.51	0.71	0.62	0.68	-0.7	-0.9		0.66	0.7	0.08	-0.48	0.69	0.9	0.83	0.7	-0.26	0.9	0.84	0.91	0.82	0.56	0.73
Cash	0.86	-0.55	0.9	0.73	0.68	0.75	0.72	0.87	-0.99	-0.78	0.66		0.86	0.47	-0.46	0.84	0.81	0.74	0.47	0.03	0.84	0.88	0.87	0.76	0.42	0.82
Non Current Assets Total	0.71	-0.5	0.89	0.76	0.51	0.9	0.58	1.0	-0.85	-0.86	0.7	0.86		0.56	-0.27	0.67	0.85	0.92	0.49	-0.05	0.87	0.77	0.88	0.76	0.12	0.99
Non Currrent Assets Other	0.07	-0.24	0.42	0.39	-0.08	0.63	0.0	0.57	-0.49	-0.37	0.08	0.47	0.56		-0.41	0.05	0.12	0.43	0.26	-0.16	0.22	0.08	0.25	0.32	-0.43	0.56
Long Term Debt	-0.38	0.66	-0.41	-0.45	-0.34	-0.31	-0.37	-0.27	0.59	0.37	-0.48	-0.46	-0.27	-0.41		-0.36	-0.35	-0.27	-0.54	0.48	-0.42	-0.3	-0.44	-0.3	-0.42	-0.3
Cash And Short Term Investments	1.0	-0.71	0.7	0.58	0.94	0.53	0.96	0.67	-0.85	-0.69	0.69	0.84	0.67	0.05	-0.36		0.87	0.53	0.62	-0.18	0.87	0.92	0.87	0.51	0.77	0.63
Common Stock Total Equity	0.9	-0.68	0.86	0.77	0.75	0.73	0.82	0.84	-0.83	-0.88	0.9	0.81	0.85	0.12	-0.35	0.87		0.83	0.63	-0.18	0.99	0.92	0.98	0.73	0.57	0.85
Common Stock Shares Outstanding	0.58	-0.46	0.93	0.89	0.3	0.92	0.41	0.91	-0.73	-0.93	0.83	0.74	0.92	0.43	-0.27	0.53	0.83		0.46	-0.03	0.84	0.74	0.86	0.91	0.1	0.94
Long Term Debt Total	0.65	-0.92	0.49	0.61	0.56	0.56	0.69	0.47	-0.55	-0.66	0.7	0.47	0.49	0.26	-0.54	0.62	0.63	0.46		-0.64	0.69	0.57	0.7	0.34	0.53	0.53
Non Current Liabilities Total	-0.19	0.76	0.07	-0.25	-0.19	-0.27	-0.37	-0.03	0.11	0.28	-0.26	0.03	-0.05	-0.16	0.48	-0.18	-0.18	-0.03	-0.64		-0.21	0.02	-0.22	0.2	-0.24	-0.12
Capital Surpluse	0.9	-0.72	0.88	0.78	0.75	0.76	0.82	0.87	-0.87	-0.89	0.9	0.84	0.87	0.22	-0.42	0.87	0.99	0.84	0.69	-0.21		0.92	0.99	0.74	0.55	0.88
Other Current Assets	0.94	-0.6	0.89	0.76	0.76	0.66	0.81	0.77	-0.86	-0.83	0.84	0.88	0.77	0.08	-0.3	0.92	0.92	0.74	0.57	0.02	0.92		0.93	0.79	0.66	0.74
Other Stockholder Equity	0.9	-0.74	0.91	0.84	0.72	0.81	0.8	0.87	-0.89	-0.93	0.91	0.87	0.88	0.25	-0.44	0.87	0.98	0.86	0.7	-0.22	0.99	0.93		0.78	0.54	0.88
Total Liab	0.55	-0.33	0.95	0.89	0.24	0.77	0.31	0.76	-0.72	-0.85	0.82	0.76	0.76	0.32	-0.3	0.51	0.73	0.91	0.34	0.2	0.74	0.79	0.78		0.21	0.76
Net Invested Capital	0.76	-0.62	0.32	0.29	0.8	0.02	0.79	0.11	-0.46	-0.33	0.56	0.42	0.12	-0.43	-0.42	0.77	0.57	0.1	0.53	-0.24	0.55	0.66	0.54	0.21		0.1
Property Plant And Equipment Gross	0.68	-0.53	0.88	0.78	0.47	0.91	0.56	0.99	-0.82	-0.88	0.73	0.82	0.99	0.56	-0.3	0.63	0.85	0.94	0.53	-0.12	0.88	0.74	0.88	0.76	0.1

Click cells to compare fundamentals

Equillium Account Relationship Matchups

Equillium fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	55.5M	85.4M	85.4M	78.4M	50.5M	67.5M
Short Long Term Debt Total	9.7M	9.9M	10.6M	10.2M	824K	782.8K
Other Current Liab	2.0M	2.8M	5.9M	10.7M	6.3M	4.5M
Total Current Liabilities	3.9M	7.2M	8.9M	32.0M	27.6M	29.0M
Total Stockholder Equity	41.8M	69.9M	66.5M	31.9M	22.6M	21.4M
Other Liab	200K	127K	54K	10.4M	11.9M	12.5M
Net Tangible Assets	41.8M	69.9M	66.5M	31.9M	36.7M	50.0M
Property Plant And Equipment Net	93K	239K	1.6M	1.2M	1.1M	682.7K
Net Debt	(3.5M)	(15.7M)	(40.4M)	(48.9M)	(22.4M)	(23.5M)
Retained Earnings	(41.1M)	(70.9M)	(110.0M)	(172.4M)	(185.7M)	(176.5M)
Accounts Payable	1.9M	2.8M	1.2M	4.0M	4.7M	2.5M
Cash	13.2M	24.0M	50.4M	59.1M	23.2M	32.3M
Non Current Assets Total	108K	254K	1.6M	1.2M	1.2M	698.4K
Non Currrent Assets Other	(93K)	(239K)	153K	104K	70K	73.5K
Long Term Debt	9.7M	8.3M	8.8M	3.2M	3.7M	7.0M
Cash And Short Term Investments	53.1M	82.2M	80.7M	71.0M	40.9M	63.0M
Common Stock Shares Outstanding	17.4M	20.4M	28.8M	33.7M	34.7M	25.8M
Short Term Investments	39.9M	58.2M	30.3M	11.9M	17.7M	22.3M
Liabilities And Stockholders Equity	55.5M	85.4M	85.4M	78.4M	50.5M	67.5M
Non Current Liabilities Total	9.8M	8.3M	10.0M	14.4M	384K	364.8K
Capital Surpluse	80.4M	82.9M	141.1M	176.6M	203.1M	105.8M
Other Current Assets	2.4M	3.3M	3.0M	4.5M	2.2M	2.6M
Other Stockholder Equity	82.9M	141.1M	176.6M	204.3M	208.2M	140.4M
Total Liab	13.7M	15.6M	18.9M	46.5M	28.0M	21.1M
Net Invested Capital	51.5M	79.8M	8.8M	40.9M	22.6M	31.3M
Property Plant And Equipment Gross	93K	239K	1.6M	1.2M	1.5M	739.9K
Total Current Assets	55.5M	85.4M	83.8M	77.2M	49.3M	66.9M
Accumulated Other Comprehensive Income	21K	(297K)	(138K)	76K	140K	147K
Non Current Liabilities Other	127K	54K	1.2M	4.1M	4.7M	4.9M
Net Working Capital	51.5M	77.9M	74.8M	44.7M	21.8M	20.7M
Common Stock	789.0	1K	2K	3K	3.5K	1.9K
Property Plant Equipment	93K	239K	237K	1.6M	1.8M	1.9M
Other Assets	(108K)	(254K)	153K	3.4M	1.0	0.95

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

0.57	RNXT	RenovoRx	Pair Corr
0.55	MDGL	Madrigal Pharmaceuticals	Pair Corr

The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.

The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC